Dr. Nigel Levens
Vice-President, Research

Dr. Levens brings to BELLUS Health 27 years of research in the field of metabolic and cardiovascular diseases in both Europe and North America. Prior to joining Innodia Inc. in 2006, he worked as Head of Biology for Biovitrum AB of Sweden, which specializes in metabolic diseases such as Type II diabetes, obesity, and metabolic syndrome. From 1998-2003, he served as Head of the Division of Metabolic Diseases for the Servier Research Group in France and prior to that as Head of Obesity Pharmacology for Novartis Pharma in Basel, Switzerland.

Educated in both the United Kingdom and the United States, Dr. Levens holds a B.Sc. (Hons.) in Physiology and Biochemistry, and a Ph.D. in Physiology from the University of Southampton in the United Kingdom, and conducted a postdoctoral fellowship in pharmacology at the University of Virginia.